Skip to evidence report

ASPC.inflammatory: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,252 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.inflammatory
#Trait / studyIndividual trait IDMean IC score
1Hallux valgus (acquired)FING0000060188.03
2Inguinal herniaFING0000068173.72
3Osteoporosis, osteopenia and pathological fracture (PheCode 743)GCST9047625853.83
4Intraocular pressure (confirmatory factor analysis Factor 26)GCST9030936053.33
5Hip indexGCST01222951.35
6HerniaFING0000061650.29
7Abdominal hernia | digestiveUKBB0000000250.06
8Pulse pressureGCST9030170349.97
9Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressureUKBB0000037649.40
10Inguinal hernia | digestiveUKBB0000036249.40
11Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary OperationsUKBB0000058749.35
12Inguinal hernia | HerniaUKBB0000036348.10
13CBLN4 levelsGCST9046855447.77
14Waist-hip indexGCST9002002745.87
15A body shape indexGCST9002002445.83
16Waist-to-hip ratio adjusted for BMIGCST9002002545.42
17Pulse pressureGCST9047278544.87
18Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressureUKBB0000037744.48
19Abdominal hernia (PheCode 550)GCST9047605942.88
20Impedance of arm left (UKB data field 23110)GCST9046817142.45
21Impedance of arm right (UKB data field 23109)GCST9046817241.97
22Hip indexGCST9002002641.48
23HSPG2/IGFBP6 ratioGCST9031509141.26
24Waist circumference adjusted for body mass indexGCST9002002941.11
25VNN2 levelsGCST9061851041.01
26Pulse pressureGCST9030170140.28
27Carpal tunnel syndromeFING0000025739.69
28Autorefraction - 6mm asymmetry index (right) | EyesightUKBB0000007439.52
29Osteoporosis NOS (PheCode 743.11)GCST9047626039.31
30Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heelUKBB0000032138.12
31T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST9032060537.96
32Oblique pelvic inlet lengthGCST9044890937.83
33Hip width to body height ratioGCST9027026037.70
34Osteoporosis (PheCode 743.1)GCST9047625936.14
35Heel bone mineral density (BMD) (left) | Bone-densitometry of heelUKBB0000031335.65
36ROBO2 levelsGCST9047049034.99
37Other specified and unspecified disorders of lensFING0000110134.69
38Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heelUKBB0000032234.64
39Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heelUKBB0000031634.63
40Central corneal thicknessGCST00636634.52
41Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heelUKBB0000032332.43
42Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heelUKBB0000031732.42
43Impedance of arm (right) | Impedance measuresUKBB0000035732.35
44Gout (PheCode 274.1)GCST9004366232.23
45Autorefraction - 6mm strong meridian (left) | EyesightUKBB0000007531.97
46Heel broadband ultrasound attenuation (left) | Bone-densitometry of heelUKBB0000031931.92
47Heel bone mineral density (BMD) (right) | Bone-densitometry of heelUKBB0000031431.84
48Prescriptions - latanoprost | prostaglandin analogUKBB0000068631.77
49Impedance of arm (left) | Impedance measuresUKBB0000035631.46
50Bone density (confirmatory factor analysis Factor 19)GCST9030935331.40
51Autorefraction - 6mm weak meridian (left) | EyesightUKBB0000007930.98
52Waist-to-Hip ratio | Body measurementUKBB0000090530.96
53Corneal resistance factorGCST9010056830.78
54Phenylalanine levelsGCST9024340730.74
55EGFR/FAP ratioGCST9031461330.37
56TNXB levelsGCST9047093030.26
57Pulse pressureGCST9030170229.97
58Ankle spacing width | Bone-densitometry of heelUKBB0000003529.90
59Waist-hip indexGCST01222829.48
60Subclinical hyperthyroidism in pregnancyGCST9043519929.47
61aparc-DKTatlas rh area inferiorparietalGCST9000327129.43
62Corneal resistance factor (left) | Intraocular pressureUKBB0000015029.38
63Ventral hernia (PheCode 550.5)GCST9047606329.02
64Dupuytren's diseaseGCST9030125228.49
65Impedance of whole body (UKB data field 23106)GCST9046817328.04
66Pulse pressure, automated reading | Cardiovascular measurementUKBB0000071427.90
67Waist-to-hip ratio adjusted for BMIGCST01223027.90
68Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heelUKBB0000032427.77
69Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heelUKBB0000031827.77
70Ribothymidine levels in chronic kidney diseaseGCST9025755427.58
71COL6A3/CST3 ratioGCST9031417427.48
72Heel bone mineral density (BMD) | Bone-densitometry of heelUKBB0000031527.45
73Inguinal hernia (PheCode 550.1)GCST9047606027.43
74Pelvic organ prolapseGCST9010247027.28
75IGFBP6/SMOC2 ratioGCST9031513827.27
76Pulse pressureGCST9047278327.22
77Operation code - inguinal/femoral hernia repair | OperationsUKBB0000056127.16
78ROBO2/SCARF2 ratioGCST9031578427.07
79Prescriptions - prostaglandin analogUKBB0000069727.06
80Pulse pressure, automated reading | Cardiovascular measurementUKBB0000071527.01
81Waist circumference adjusted for body mass indexGCST9030289227.01
82Dermatochalasis (PheCode 374.6)GCST9047589426.80
83T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90)GCST9032090926.78
84Corneal hysteresis (left) | Intraocular pressureUKBB0000014826.64
85Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB0000071826.44
86COL6A3/SMOC2 ratioGCST9031417826.33
87Corneal resistance factor (right) | Intraocular pressureUKBB0000015126.28
88Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB0000071925.99
89QC T1 inverse SNRGCST9000634825.96
90FGR levelsGCST9046923625.93
91FAP levelsGCST9046918925.85
92Fracture of forearmGCST9028127325.68
93CNTN1 levelsGCST9046880325.37
94Corneal resistance factorGCST9030868225.23
95IDP T1 FAST ROIs R occ poleGCST9000254625.22
96Open-angle glaucoma (PheCode 365.1)GCST9047587225.05
97Eye conditions (confirmatory factor analysis Factor 25)GCST9030935925.01
98Corneal hysteresis (right) | Intraocular pressureUKBB0000014924.68
99DLK1/FAP ratioGCST9031449124.59
100Takes medication for Macular Degeneration?GCST9047538724.53
101Autorefraction - 3mm weak meridian (left) | EyesightUKBB0000006924.36
102Autorefraction - 3mm strong meridian (left) | EyesightUKBB0000006524.15
103Heel bone mineral densityGCST00628824.10
104aparc-Desikan rh area inferiorparietalGCST9000311423.96
105VCAN levelsGCST9047103223.91
106Pelvic widthGCST9044891123.73
107Heel broadband ultrasound attenuation (right) | Bone-densitometry of heelUKBB0000032023.68
108Female genital prolapse | Noninflammatory disorders of female genital tractUKBB0000024423.68
109Fracture of forearmFING0000055423.60
110TNC/VCAM1 ratioGCST9031592723.45
111Waist-to-hip ratio adjusted for BMIGCST9002599623.42
112BOC levelsGCST9046845823.40
113Autorefraction - 3mm weak meridian (right) | EyesightUKBB0000007023.30
114COL4A1 levelsGCST9046881823.04
115Autorefraction - 6mm weak meridian (right) | EyesightUKBB0000008023.01
116CLMP/PIK3IP1 ratioGCST9031413422.89
117aseg global volume-ratio BrainSegVol-to-eTIVGCST9000261222.80
118Female genital prolapseFING0000053522.59
119GlaucomaGCST9047586922.51
120CD200R1 levelsGCST9046860522.49
121Autorefraction - 3mm strong meridian (right) | EyesightUKBB0000006622.47
122Subpubic angleGCST9044890822.45
123ScoliosisFING0000128122.33
124Macular degenerationGCST9047538622.19
125Autorefraction - 6mm asymmetry index (left) | EyesightUKBB0000007322.00
126DTI autoptx FA str r tractGCST9038513621.91
127Autorefraction - 6mm strong meridian (right) | EyesightUKBB0000007621.77
128Other mental disorders due to brain damage and dysfunction and to physical diseaseFING0000107221.76
129Pulse pressureGCST9031029621.67
130Primary open-angle glaucoma, strictFING0000121421.65
131EGFR levelsGCST9046908521.64
132aparc-a2009s lh volume G-precentralGCST9000295321.61
133Umbilical hernia | digestiveUKBB0000088021.61
134IDP dMRI ProbtrackX L3 unc lGCST9000432521.55
135aparc-a2009s lh volume S-centralGCST9000296921.50
136Impedance of whole body | Impedance measuresUKBB0000036021.39
137Macular degeneration, wet (PheCode 362.22)GCST9047585221.22
138ZNRF4 levelsGCST9047110421.20
139Umbilical hernia | HerniaUKBB0000088121.15
140Diaphragmatic hernia (PheCode 550.2)GCST9047606121.15
141Prolapse of vaginal walls | genitourinaryUKBB0000071221.13
142C21orf58 levelsGCST9061838021.12
143TNC levelsGCST9047089520.82
144aparc-a2009s rh volume S-centralGCST9000304320.76
145Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB0000071620.69
146Pelvic inlet widthGCST9044891020.69
147aparc-pial rh area inferiorparietalGCST9000318120.66
148SCARA5 levelsGCST9047053320.51
149REST UKBBICA NET100 1287GCST9038714120.48
150COL6A3/COLEC12 ratioGCST9031417320.34
151Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB0000071720.33
152Appendicular lean massGCST9000002720.32
153Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB0000072020.13
154IDP dMRI ProbtrackX MD unc lGCST9000424420.03
155Forced expiratory volume in 1-second (FEV1), predicted | SpirometryUKBB0000025219.93
156Haemorrhoidal diseaseGCST9001403319.93
157Genital prolapse | genitourinaryUKBB0000028219.85
158Glaucoma (multi-trait analysis)GCST00972219.65
159Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB0000072119.61
160Intraocular pressureGCST00407419.59
161Autorefraction - 3mm strong meridian angle (left) | EyesightUKBB0000006719.41
162RET levelsGCST9047045819.38
163Retinal breaks without detachmentFING0000125819.33
164Impedance of leg (right) | Impedance measuresUKBB0000035919.31
165Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemiaGCST9062474419.23
166Hallux valgus (Bunion) (PheCode 735.3)GCST9047625119.20
167Alzheimer's disease (MTAG)GCST9044905519.19
168ENG levelsGCST9046910819.13
169Diaphragmatic herniaFING0000041919.07
170Descending aorta diameterGCST9026739118.90
171CTSD/PRCP ratioGCST9031431218.89
172HSPG2/SMOC2 ratioGCST9031509318.81
173RFC4 levelsGCST9047046018.60
174Hip circumference adjusted for BMIGCST9002002818.59
175Macular degeneration (senile) of retina NOS (PheCode 362.29)GCST9047585718.53
176LGALS3 levelsGCST9046976118.52
177Impedance of leg (left) | Impedance measuresUKBB0000035818.51
178Hereditary deficiency of other clotting factorsFING0000061218.48
179BCL2 levelsGCST9046843318.47
180Iliac isthmus breadthGCST9044890718.39
181BA-exvivo lh area entorhinalGCST9000322018.37
182Volume of left paralaminar nucleusGCST9047498218.25
183Haemorrhoids and perianal venous thrombosisFING0000059918.16
184IDP dMRI TBSS L2 Sagittal stratum LGCST9000415418.14
185BA-exvivo lh volume BA3aGCST9000283718.05
186IDP T1 FAST ROIs V cerebellum VIIIaGCST9000257917.97
187Glaucoma suspectFING0000057917.94
188MAMDC2 levelsGCST9046984117.88
189Lung function (FVC)GCST00742917.86
190IDP dMRI TBSS L1 External capsule LGCST9000410817.81
191Deforming dorsopathiesFING0000038517.73
192SLITRK6 levelsGCST9047067117.71
193Umbilical hernia (PheCode 550.4)GCST9047606217.60
194Pulse pressureGCST9047278417.59
195Disorders of choroid and retinaFING0000043817.59
196ERBB3 levelsGCST9046914017.52
197CASP1 levelsGCST9046854317.50
198Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3ECGU00000317.44
199Primary open angle glaucoma (PheCode 365.11)GCST9047587517.41
200Tibia length to body height ratioGCST9027025817.41
201IDP dMRI TBSS MD External capsule LGCST9000406017.36
202Calcific aortic valve stenosisGCST9031029317.32
203AOC3 levelsGCST9046832217.19
204COL6A3/OGN ratioGCST9031417717.05
205HeightGCST9027863717.00
206IDP dMRI ProbtrackX MO str rGCST9000402416.98
207IDP dMRI ProbtrackX L3 unc rGCST9000432616.98
208DTI autoptx L3 str r tractGCST9038521716.97
209Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5ECGU00000516.93
210Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4ECGU00000416.88
211Forced vital capacity (FVC) | SpirometryUKBB0000025416.88
212Coronary artery calcificationGCST9027845616.85
213Incisional hernia (PheCode 550.6)GCST9047606416.71
214Free testosterone levelsGCST9023982616.53
215Mean volume of bilateral amygdalaGCST9047499416.23
216Undecenoylcarnitine (C11:1) levelsGCST9020023616.15
217Diverticular disease of intestine | Other diseases of intestinesUKBB0000018916.08
218aparc-Desikan lh volume precentralGCST9000279116.08
219HeightGCST9001873915.99
220Ankle spacing width (right) | Bone-densitometry of heelUKBB0000003415.95
221Volume of right accessory basal nucleusGCST9047500615.91
222T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST9032062015.91
223Illnesses of father - Heart disease | Family historyUKBB0000034215.88
224Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB0000042915.86
225T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123)GCST9032068615.83
226Volume of left basal nucleusGCST9047494615.81
227CDON/SCARA5 ratioGCST9031399515.77
228Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9ECGU00000915.65
229Pelvic heightGCST9044891215.54
230Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8ECGU00000815.50
231Maximum indexed left atrial volumeGCST9001901215.43
232Takes medication for Glaucoma?GCST9047538415.42
233Retinal thickness (functional principal component 2)GCST9045572215.40
234Appendicular lean massGCST9000002515.35
235BPIFB1/GLRX ratioGCST9031353015.32
236Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2ECGU00000215.31
237T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST9032064515.25
238Waist circumference adjusted for body mass indexGCST01222615.25
239Diverticulosis and diverticulitis (PheCode 562)GCST9047607315.25
240CCN3/FAP ratioGCST9031372115.20
241CXCL10/WARS ratioGCST9031433215.20
242Hypertrophy of breastFING0000064415.20
243Diverticulosis and diverticulitis | digestiveUKBB0000019115.18
244DTI autoptx L2 str r tractGCST9038519015.14
245Forearm length to body height ratioGCST9027025715.13
246Appendicular lean massGCST9000002615.11
247Forced vital capacity FVC Z score (UKB data field 20257)GCST9046816715.05
248Tetradecadienedioate (C14:2-DC) metabolite levelGCST9061627515.03
249Diverticulosis | digestiveUKBB0000019014.97
250HRC levelsGCST9046947514.96
251SRPX levelsGCST9047074414.94
252Ankle spacing width (left) | Bone-densitometry of heelUKBB0000003314.92
253C7 levelsGCST9042233214.89
254diastolic blood pressure (DBP, mean, inv-normal transformed)GCST9047525514.82
255Pulse pressure (BMI adjusted)GCST9033516714.82
256KeloidGCST9065248814.79
257COMP/DPP4 ratioGCST9031418814.72
258Glaucoma (primary open-angle)GCST9039972514.71
259BA-exvivo lh volume entorhinalGCST9000284814.68
260HEG1 levelsGCST9046944414.62
261EIF4G1/TBC1D23 ratioGCST9031463914.60
262VWF levelsGCST9047106514.60
263Volume of right basal nucleusGCST9047501214.56
264FOLH1 levelsGCST9042719214.54
265BCAN/DPP6 ratioGCST9031347814.44
266Sitting height | Body size measuresUKBB0000077114.40
267Diverticulosis (PheCode 562.1)GCST9047607614.38
268Angina pectorisGCST9001857314.37
269Progressive vascular leukoencephalopathyFING0000121814.27
270aparc-DKTatlas lh volume precentralGCST9000288414.26
271Operative procedures - Haemorrhoidectomy | Summary OperationsUKBB0000058014.24
272Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6ECGU00000614.18
273Synovitis and tenosynovitis (PheCode 727.1)GCST9047624214.16
274Bone density T-scoreGCST9027862014.10
275Barrett's esophagus (PheCode 530.13)GCST9047604814.08
276Other aneurysm (PheCode 442)GCST9047599214.05
277EFEMP1/FSTL3 ratioGCST9031459514.05
278Blood cell traits latent factor 21 (red cell)GCST9055926314.04
279Hand grip strength right (UKB data field 47)GCST9046816914.03
280POSTN levelsGCST9047028813.91
281Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST9029158213.87
282BA-exvivo rh volume BA3aGCST9000285113.85
283Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB0000055713.84
284Diaphragmatic hernia | digestiveUKBB0000017113.81
285Operative procedures - Angiocardiography of left side of heart NEC | Summary OperationsUKBB0000057213.79
286height (mean, inv-normal transformed)GCST9047536213.74
287PTPRF/PTPRS ratioGCST9031575113.72
288SIL1 levelsGCST9047063813.68
289Volume of right lateral nucleusGCST9047503413.68
290IDP dMRI ProbtrackX L2 unc lGCST9000429813.64
291Autorefraction - 6mm strong meridian angle (right) | EyesightUKBB0000007813.61
292IDP dMRI ProbtrackX MD unc rGCST9000424513.58
293Height (maximum, inv-normal transformed)GCST9047535913.55
294PILRA/TNFRSF1A ratioGCST9031565513.54
295Hand grip strength left (UKB data field 46)GCST9046816813.51
296T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37)GCST9032085613.51
297Aortic aneurysm (PheCode 442.1)GCST9047599313.49
298Calcific aortic valvular stenosis, operatedFING0000023413.47
299ALB levelsGCST9047510313.42
300IDP dMRI ProbtrackX L2 ilf lGCST9000428713.36
301Volume of right cortico-amygdaloid transition areaGCST9047501813.35
302Valine levelsGCST9024345313.31
303Glaucoma (primary open-angle)GCST9001176813.28
304Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7ECGU00000713.27
305CD34 levelsGCST9046862613.26
306T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST9032088713.21
307Bone density Z-scoreGCST9027862113.18
308Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST9030277913.16
309X-17676 levelsGCST9020054813.12
310ADGRD1 levelsGCST9046823513.12
311PSPN levelsGCST9047036413.09
312Treatment speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB0000083513.08
313Nerve, nerve root and plexus disordersFING0000086213.07
314height (minimum, inv-normal transformed)GCST9047536513.06
315aseg global volume WM-hypointensitiesGCST9000260413.05
316IDP dMRI ProbtrackX FA ilf lGCST9000393913.00
317CDON levelsGCST9046868713.00
318PON1 levelsGCST9047028512.99
319MATN2 levelsGCST9046986412.98
320MCEE levelsGCST9046987112.93
321T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59)GCST9032087812.88
322T1 FreeSurfer DKT rh fusiform thicknessGCST9038432212.80
323Hand grip strength (right) | Hand grip strengthUKBB0000030112.77
324Peritonsillar abscessFING0000116012.76
325ST6GALNAC2 levelsGCST9024025112.74
326BA-exvivo rh volume BA4pGCST9000285412.67
327LTBP2 levelsGCST9046981412.63
328ADAMTS8 levelsGCST9046822712.60
329Urine glucuronide of C10H18O2 (12)* levels in chronic kidney diseaseGCST9026518912.57
330Autorefraction - 3mm cylindrical power (left) | EyesightUKBB0000006212.56
331Nonrheumatic aortic valve disorders (PheCode 395.2)GCST9047591412.53
332CD69/CDKN2D ratioGCST9031386612.49
333Lung cancerGCST9001181212.49
334FracturesGCST00698012.47
335GlaucomaGCST9047538312.32
336FUT8/TNFSF14 ratioGCST9031489512.29
337Systolic blood pressureGCST9030169712.24
338Age-related eyesight deterioration (confirmatory factor analysis Factor 27)GCST9030936112.21
339DNAJA2/PLXNA4 ratioGCST9031450412.18
340DTI autoptx MD unc l tractGCST9038524512.15
341PRELP levelsGCST9047032112.11
342Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary OperationsUKBB0000058312.10
343Kyphosis (MTAG)GCST9057004712.10
344ALB levelsGCST9047510612.05
345TNN levelsGCST9047092712.04
346Triglyceride to HDL cholesterol ratioGCST9029595112.00
347CCDC80/CCL27 ratioGCST9031366911.99
348What is your height? (cm, inv-normal transformed)GCST9047536811.99
349Fractured/broken bones in last 5 years | Medical conditionsUKBB0000025811.98
350PLXDC2 levelsGCST9047026411.98
351Pulse pressure (BMI unadjusted)GCST9033516611.98
352T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40)GCST9032085911.96
353Hereditary corneal dystrophiesFING0000061111.93
354CTSO/IGF2R ratioGCST9031431711.93
355COLEC12/TGFBR2 ratioGCST9031418611.89
356Abdominal aortic aneurysm (PheCode 442.11)GCST9047599411.88
357Umbilical herniaFING0000139511.86
358Sleep apnea (MTAG) (adjusted for BMI)GCST9026736411.85
359Volume of right basal nucleusGCST9047491011.84
360Hip circumference adjusted for BMIGCST01222711.82
361Depression/anxiety (weighted GWA)GCST9026727711.81
362Cereal type - Oat cereal (e.g. Ready Brek, porridge) | DietUKBB0000012411.80
363Intra-ocular pressure, corneal-compensated (left) | Intraocular pressureUKBB0000037411.78
364COMP/MYOC ratioGCST9031419111.76
365Tonsillectomy and adenotomyFING0000136711.76
366A body shape indexGCST01223111.76
367Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1ECGU00000111.76
368BTN2A1/SMOC2 ratioGCST9031354911.74
369Perforation of tympanic membraneFING0000115511.67
370Other joint disordersFING0000106411.65
371Seated height | Body size measuresUKBB0000076311.65
372PAMR1 levelsGCST9047015511.57
373aparc-DKTatlas lh area entorhinalGCST9000323811.55
374Femur length to body height ratioGCST9027025611.55
375T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24)GCST9032058711.54
376IDP dMRI ProbtrackX L2 unc rGCST9000429911.54
377aparc-a2009s lh area S-collat-transv-antGCST9000334611.54
378EFEMP1/TGFBR3 ratioGCST9031459711.49
379Low hand grip strength (60 years and older) (EWGSOP)GCST9000752611.49
380DTI TBSS L3 Retrolenticular part of internal capsule LGCST9038454511.48
381MXRA8 levelsGCST9046996811.41
382T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75)GCST9032089411.39
383Volume of left whole amygdalaGCST9047498811.33
384INHBC levelsGCST9046961511.33
385ADAMTSL2 levelsGCST9046822811.33
386Osteopenia or other disorder of bone and cartilage (PheCode 743.9)GCST9047626111.31
387Fibroblastic disorders | Other soft tissue disordersUKBB0000024611.30
388Body fat percentage (adjusted for testosterone and SHBG)GCST9043217911.30
389T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77)GCST9032089611.30
390Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary OperationsUKBB0000057111.29
391IDP dMRI ProbtrackX MD cgh lGCST9000422511.29
392Use of antiglaucoma preparations and mioticsFING0000140911.26
393ICD10 N81: Female genital prolapseGCST9045421411.25
394IGF1 levelsGCST9002598911.22
395Intra-ocular pressure, corneal-compensated (right) | Intraocular pressureUKBB0000037511.21
396T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST9032063111.14
397GlaucomaFING0000057711.13
398BA-exvivo lh thickness BA4aGCST9000351711.09
399GlaucomaGCST9001863211.09
400HSPG2 levelsGCST9017939211.06
401FCRL2/TNFRSF13B ratioGCST9031480111.05
402Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARBUKBB0000069011.03
403Free androgen indexGCST9023982411.01
404aparc-a2009s rh volume G-front-inf-TriangulGCST9000301210.99
405T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39)GCST9032085810.98
406Thoracic aortic aneurysmFING0000135710.96
407MSMB levelsGCST9046994910.95
408T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91)GCST9032065410.91
409Intestinal infectious diseasesFING0000068910.89
410Intracerebral hemorrhageGCST9001865010.83
411PON3 levelsGCST9047028710.81
412Systolic blood pressure (weighted GWA)GCST9026730510.81
413GAPDH levelsGCST9046930210.79
414COL6A3/HSPG2 ratioGCST9031417510.79
415Aortic aneurysmFING0000010210.78
416Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levelsGCST9006027710.77
417Glaucoma (primary open-angle)GCST9001176610.77
418COLEC12/OGN ratioGCST9031418410.77
419aseg global volume EstimatedTotalIntraCranialGCST9000259710.76
420Total protein levelsGCST9002599510.74
421DPP6/SEZ6L ratioGCST9031454410.67
422ITGA11 levelsGCST9046963310.66
423Coronary artery plaque burdenGCST9050307510.61
424Illnesses of mother - None of the above (group 1) | Family historyUKBB0000034910.61
425Drusen (degenerative) of retina (PheCode 362.27)GCST9047585510.57
426Trunk fat percentage | Impedance measuresUKBB0000086410.57
427Contracture of palmar fascia [Dupuytren's disease] | musculoskeletalUKBB0000014610.55
428QC rfMRI-to-T1 linear alignment discrepancyGCST9000635310.53
429Inguinal hernia, bilateralFING0000068210.50
430Medication use (antithrombotic agents)GCST9001876210.49
431HeightGCST9030289010.45
432ADGRB3 levelsGCST9046823410.43
433AGRN/HSPG2 ratioGCST9031320110.43
434T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26)GCST9032084510.43
435T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46)GCST9032060910.40
436T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11)GCST9032057410.39
437Myopia (PheCode 367.1)GCST9047588010.38
438CHRDL1/SMOC2 ratioGCST9031406210.38
439Disorders of muscle, ligament, and fascia | musculoskeletalUKBB0000018710.36
440ASPN levelsGCST9046837710.36
441BlepharochalasisFING0000022010.35
442CCN3 levelsGCST9046858910.31
443NPL levelsGCST9047007210.28
444Gestational age at birth (child effect)GCST9026842110.27
445Operation code - carpal tunnel surgery | OperationsUKBB0000055310.27
446Anterior thigh muscle fat infiltration percentageGCST9026735110.26
447SSC5D levelsGCST9047074810.26
448Standing height | Body size measuresUKBB0000079610.24
449PTPRH levelsGCST9047038210.22
450Body size (confirmatory factor analysis Factor 21)GCST9030935510.21
451MFAP4 levelsGCST9046989810.16
452Ventral herniaFING0000142810.15
453IDP dMRI TBSS L3 External capsule LGCST9000420410.13
454aparc-a2009s lh thickness G-cuneusGCST9000361310.11
455VIT levelsGCST9047104110.11
456PATE4 levelsGCST9024240510.10
4571-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levelsGCST9020069210.10
458Hand grip strength (left) | Hand grip strengthUKBB0000030010.09
459Liver proton density fat fractionGCST9026735210.09
460Volume of right whole amygdalaGCST9047505410.08
461IGF1 levelsGCST9046807810.06
462T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127)GCST9032069010.06
463Operative procedures - Palmar fasciectomy | Summary OperationsUKBB0000058610.03
464aparc-a2009s lh thickness G-postcentralGCST9000363010.02
465T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST9032094010.00
466Coronary angioplastyFING000003579.96
467T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903208669.96
468Diacylglycerol_38:5_[M+H-H2O]1+ levelsGCST900602009.94
469T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST903208739.93
470ALB levelsGCST904751009.89
471Cerebrospinal fluid 3-hydroxyhexanoate levelsGCST903181089.87
472ITGBL1 levelsGCST904696489.84
473Coronary atherosclerosis (PheCode 411.4)GCST900439579.79
474DLK1/PIK3IP1 ratioGCST903144929.79
475Unstable angina pectorisFING000014059.79
476PSAP levelsGCST904265869.79
477APOF levelsGCST904683399.78
478IDP dMRI TBSS MD Cingulum cingulate gyrus LGCST900040629.78
479Biological Sibling: Alzheimer's / Other DementiaGCST904763759.76
480COL6A3/TAFA5 ratioGCST903141809.75
481Hypertrophy of breast in women and menFING000006459.72
482FUS levelsGCST904692789.72
483SFRP2 levelsGCST902427279.71
484PTPRZ1 levelsGCST904703889.71
485T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903208839.68
486DTI TBSS MD Retrolenticular part of internal capsule LGCST903845939.65
487IDP dMRI TBSS L3 External capsule RGCST900042039.54
488Hand grip strength (baseline)GCST905658459.53
489IDP dMRI ProbtrackX L3 ifo rGCST900043139.50
490Retinal arteriolar widthGCST902703989.49
491Acquired foot deformities (PheCode 735)GCST904762479.49
492IDP T1 FAST ROIs L caudateGCST900025499.48
493IDP dMRI ProbtrackX FA unc rGCST900039519.47
494T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903208769.45
495Palmar fascial fibromatosis [Dupuytren]FING000011419.44
496T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST903209419.44
497NPY/SMOC1 ratioGCST903155519.42
498Benign mammary dysplasiaFING000001519.41
499OsteoporosisGCST904681459.41
500aparc-Desikan lh thickness postcentralGCST900034669.37
501GSTA4 levelsGCST902412839.34
502CD59/SCARB2 ratioGCST903138599.33
503Medication use (salicylic acid and derivatives)GCST900187759.31
504wg lh intensity-contrast middletemporalGCST900038069.31
505Anterior thigh muscle volumeGCST902673499.30
506CST3/TFF3 ratioGCST903142999.28
507ESR1 levelsGCST904691559.27
508BA-exvivo lh volume BA4pGCST900028409.21
509Standing height (UKB data field 50)GCST904681789.20
510SERPING1 levelsGCST904706009.19
511Macular degeneration, dry (PheCode 362.21)GCST904758519.18
512Carotid intima-media thickness (MTAG)GCST904490619.15
513IDP dMRI TBSS OD FornixGCST900044079.15
514QC T1-to-standard nonlinear alignment discrepancyGCST900063469.14
515T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114)GCST903206779.12
516Systolic blood pressureGCST904727829.12
517T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126)GCST903206899.10
518Autorefraction - 3mm cylindrical power (right) | EyesightUKBB000000639.09
519ITGB1 levelsGCST904696439.09
520DPP6/SEZ6L2 ratioGCST903145439.07
521Coronary artery calcificationGCST905030749.06
522T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903206049.06
523Height, inverse-rank normalizedFING000006079.05
524IDP dMRI ProbtrackX L3 ilf lGCST900043149.04
525T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76)GCST903208959.03
526HGF/TNFSF14 ratioGCST903150609.02
527DTI TBSS L3 Superior corona radiata LGCST903845499.01
528Other menopausal disordersFING000010719.00
529NRP1 levelsGCST904700859.00
530FST levelsGCST904692739.00
531Corneal opacity and other disorders of cornea (PheCode 364)GCST904758618.97
532Descending aorta distensibilityGCST902673868.95
533T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51)GCST903206148.95
534IDP dMRI TBSS L1 External capsule RGCST900041078.93
535OMD levelsGCST904701238.93
536IDP dMRI TBSS MD External capsule RGCST900040598.91
537DKKL1 levelsGCST904690008.91
538aparc-DKTatlas lh thickness cuneusGCST900035438.90
539PLXDC1 levelsGCST904702638.89
540NOTCH3/PTPRS ratioGCST903155478.89
541Diacylglycerol (18:0_18:1) levelsGCST900247148.89
542Other hammer toe(s) (acquired)FING000010548.84
543Hernia of abdominal wallFING000006178.82
544LAMP1 levelsGCST904697338.82
545BA-exvivo rh volume BA3bGCST900028528.82
546Total thigh muscle volume z-scoreGCST902673568.80
547TNFRSF14/TNFSF14 ratioGCST903159368.80
548IDP dMRI TBSS L2 Retrolenticular part of internal capsule LGCST900041448.78
549ALKBH3 levelsGCST906190958.78
550aparc-Desikan rh thickness paracentralGCST900034958.77
551ENPP7 levelsGCST904691188.77
552Diaphragmatic hernia | HerniaUKBB000001728.76
553CD109 levelsGCST904685978.76
554aparc-DKTatlas rh volume parstriangularisGCST900029118.74
555Takes medication for heart attack?GCST904752128.73
556ITGAM/ITGAV ratioGCST903152098.71
557systolic blood pressure (SBP, mean, inv-normal transformed)GCST904764038.71
558GGH/INHBC ratioGCST903149288.69
559IGF1 levelsUKBB000003378.68
560Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levelsGCST900603038.67
561wg rh intensity-contrast caudalmiddlefrontalGCST900038308.66
562aparc-DKTatlas lh thickness postcentralGCST900035608.64
563CFHR4 levelsGCST900190458.64
564Stable angina pectorisGCST900186958.64
565Osteoarthrosis | musculoskeletalUKBB000005968.62
566OLR1 levelsGCST900120208.61
567Operation code - varicose vein surgery | OperationsUKBB000005688.61
568wg lh intensity-contrast transversetemporalGCST900038258.60
569Operation code - inguinal hernia repair | OperationsUKBB000005608.58
570Levulinate 4-oxovalerate levelsGCST902435458.57
571Spontaneous coronary artery dissectionGCST902458788.57
572T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903206238.55
573Heart rate variability traits (SDNN)GCST0047348.55
574Left hippocampal volume (tail)GCST902679518.54
575IDP dMRI ProbtrackX MD ilf lGCST900042338.53
576SnoringGCST0097618.53
577CNTN4 levelsGCST904688068.50
578CCDC80/CHRDL1 ratioGCST903136708.49
579ICAM2 levelsGCST904694998.46
580DPP6 levelsGCST904690348.46
581RBP5 levelsGCST904704398.45
582Olsenella C abundance in stoolGCST900324938.45
583Height (baseline)GCST905658438.42
584CD164/PARK7 ratioGCST903137438.41
585Testosterone levelsGCST904834868.40
586APP/FKBP1B ratioGCST903133238.39
587ANGPTL7 levelsGCST904683068.38
588Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004468.36
589aparc-Desikan rh volume parahippocampalGCST900028168.36
590Degeneration of macula and posterior pole of retina (PheCode 362.2)GCST904758498.35
591Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004458.35
592T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58)GCST903206218.34
593SCAMP3/VPS53 ratioGCST903158078.34
594Main speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB000004198.34
595FST/FSTL3 ratioGCST903148828.33
596T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115)GCST903206788.32
597aparc-DKTatlas rh thickness paracentralGCST900035868.31
598Comparative height size at age 10 | Early life factorsUKBB000001438.31
599IDP dMRI TBSS L1 FornixGCST900040808.31
600aparc-Desikan lh thickness cuneusGCST900034498.30
601Osteoporosis | musculoskeletalUKBB000005988.29
602HHIP levelsGCST906170978.29
603Volume of right accessory basal nucleusGCST904749078.28
604VSNL1 levelsGCST904710548.27
605Coronary revascularization (ANGIO or CABG)FING000003608.27
606Benign neoplasm: Colon, unspecifiedFING000001728.25
607Benign neoplasm: Adrenal glandFING000001648.25
608Heart failure and coronary heart diseaseFING000006048.24
609Macular puckering of retina (PheCode 362.26)GCST904758548.23
610Left-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903026828.22
611Low hand grip strength (60 years and older) (EWGSOP)GCST900075278.22
612FABP2/RBP2 ratioGCST903147578.22
613SCARA5/TNC ratioGCST903158108.22
614FAP/LRRN1 ratioGCST903147838.21
615T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903208608.21
616PKD1 levelsGCST904702408.21
617T1 FreeSurfer DK lh lingual thicknessGCST903856348.21
618Falls/tendency to fallFING000005308.20
619aparc-DKTatlas rh area cuneusGCST900032688.17
620BA-exvivo rh thickness BA4aGCST900035318.17
621CHL1 levelsGCST904687458.17
622Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST903093588.16
623aparc-a2009s lh thickness G-precuneusGCST900036328.15
624T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST903205798.14
625Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22)GCST904759918.13
626Osteoporosis NOS | musculoskeletalUKBB000005998.13
627PTPRN2/RTBDN ratioGCST903157548.12
628Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10ECGU0000108.12
629IFNGR1/THBD ratioGCST903151308.11
630IDP dMRI TBSS MD Superior fronto-occipital fasciculus RGCST900040698.10
631Bioavailable testosterone levelsGCST900121048.10
632Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levelsGCST900603268.09
633AIFM1/EGF ratioGCST903132198.08
634DTI autoptx L3 unc l tractGCST903852188.06
635high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST904753488.05
636PSME2/RBKS ratioGCST903157378.04
637Succinylcarnitine levelsGCST902438748.04
638DPP4/ITGB1 ratioGCST903145408.03
639wg lh intensity-contrast caudalmiddlefrontalGCST900037958.02
640aparc-a2009s rh area S-orbital-H-ShapedGCST900034348.01
641PI16 levelsGCST904702298.01
642COL24A1 levelsGCST904688148.00
643DTI TBSS L2 Retrolenticular part of internal capsule LGCST903844977.98
644Angina pectoris | Ischaemic heart diseasesUKBB000000317.97
645IDP dMRI TBSS L1 Superior fronto-occipital fasciculus RGCST900041177.97
646DTI autoptx L2 unc l tractGCST903851917.96
647wg lh intensity-contrast superiortemporalGCST900038217.96
648Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING000001507.95
649Volume of right paralaminar nucleusGCST904750487.94
650PSG1 levelsGCST904703537.94
651Angina pectoris | circulatory systemUKBB000000307.93
652PRTG levelsGCST904703477.93
653HydroceleFING000006277.92
654IDP dMRI TBSS MD Retrolenticular part of internal capsule LGCST900040487.91
655ThalamNuclei rh volume CeMGCST900027517.90
656LEPR levelsGCST904697567.89
657IFIT2 levelsGCST900908647.89
658SPARCL1 levelsGCST904707177.87
659GFRA3 levelsGCST904693307.85
660SCARF2 levelsGCST904705377.85
661Spondylolisthesis/SpondylolysisFING000013247.84
662COMP levelsGCST904688277.83
663Fracture of rib(s), sternum and thoracic spineFING000005587.82
664Height (standard GWA)GCST902672847.82
665Lysophosphatidylethanolamine-P_20:0_[M-H]1- levelsGCST900601477.82
666DLK1 levelsGCST904690037.81
667GlaucomaGCST904681297.81
668Major coronary heart disease eventFING000007467.80
669high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753507.80
670IDP T1 FAST ROIs L front operc cortexGCST900025317.80
671DTI TBSS L1 External capsule RGCST903844607.79
672ArthropathiesFING000001077.78
673aparc-a2009s lh area G-cuneusGCST900033077.78
674LAMB1 levelsGCST904697327.78
675MAVS/PPP1R9B ratioGCST903153937.77
676Fracture of lower limb | injuries & poisoningsUKBB000002557.77
677Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004287.76
678Triacylglycerol_46:4_[M+NH4]1+ levelsGCST900603627.75
679IDP dMRI ProbtrackX L3 ilf rGCST900043157.74
680BA-exvivo lh thickness BA2GCST900035147.74
681Knee extension strengthGCST903195027.74
682Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditionsUKBB000008977.73
683L1CAM levelsGCST904697237.72
684Fracture of lower leg, including ankleFING000005557.72
685ANGPTL2 levelsGCST904683037.72
686Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivityGCST903027607.70
687IDP dMRI ProbtrackX MD ar lGCST900042197.69
688BA-exvivo rh volume BA1GCST900028497.69
689Disorders of breastFING000004377.69
690Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARBUKBB000006627.68
691Abnormalities of forces of labourFING000000037.67
692IDP dMRI TBSS MD Pontine crossing tractGCST900040287.66
693aparc-DKTatlas rh volume parahippocampalGCST900029077.66
694OsteoporosisGCST900861227.66
695Corneal dystrophy (PheCode 364.5)GCST904758647.66
696RGMB/SMOC2 ratioGCST903157707.66
697TPM2 levelsGCST902431227.65
698Cholesteryl ester (16:2) levelsGCST900246287.64
699CD79B/FCRL2 ratioGCST903139007.63
700APOM levelsGCST904683427.62
701PON2/PON3 ratioGCST903157037.62
702PECAM1/SOD2 ratioGCST903156477.62
703T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903206087.61
704Polyp of the female genital tractFING000011907.60
705DTI TBSS L3 Superior corona radiata RGCST903845487.58
706FABP5 levelsGCST904691777.58
707IDP T1 FAST ROIs R caudateGCST900025507.58
708LILRB4 levelsGCST904267087.57
709Cataract | sense organsUKBB000001207.57
710Coronary atherosclerosisFING000003597.56
711Coronary artery / coronary heart disease (including heart attack, angina)GCST904751987.56
712HMCN2 levelsGCST904694617.55
713Descending aorta strainGCST902673897.54
714Retinal detachments and defects | sense organsUKBB000007567.53
715Isoleucine levels (UKB data field 23465)GCST902695627.53
716Triacylglycerol_49:3_[M+NH4]1+ levelsGCST900604437.51
717Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4)GCST904762437.51
71810-undecenoate (11:1n1) levelsGCST902435967.50
719CST3/IGFBP6 ratioGCST903142937.49
720Glucose levelsGCST901327247.49
721NOTCH3 levelsGCST904700677.47
722C1QL2 levelsGCST904684877.46
723MATN2/SCARA5 ratioGCST903153887.46
724IDP dMRI ProbtrackX L2 atr lGCST900042757.45
725Endometriosis of ovaryFING000005017.45
726CR2/TNFRSF13B ratioGCST903142257.45
727FAP/THBS4 ratioGCST903147857.45
728Other predominantly sexually transmitted diseases, not elsewhere classifiedFING000010897.44
729ICD10 C53: Malignant neoplasm of cervix uteriGCST904542027.44
730CHCHD6 levelsGCST904687397.44
731APOM/MCAM ratioGCST903133157.41
732Humerus length to body height ratioGCST902702597.41
733Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST904762207.39
734Triacylglycerol_50:4_[M+NH4]1+ levelsGCST900604667.39
735Knee osteoarthritisGCST0070907.39
736Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST902696867.38
737Operation code - wisdom teeth surgery | OperationsUKBB000005697.37
738DTI TBSS L2 Posterior corona radiata RGCST903845027.36
739IDP dMRI TBSS MD Cingulum cingulate gyrus RGCST900040617.35
740Aspartate aminotransferase | Blood biochemistryUKBB000000527.34
741End-diastolic bi-ventricular shape (principal component 4)GCST904484837.33
742Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903028207.32
743NCR3 levelsGCST900881797.32
744HSPG2/VASN ratioGCST903150947.31
745Follicular cysts of skin and subcutaneous tissueFING000005477.31
746CCL8 levelsGCST904223467.30
747Pulmonary tuberculosisGCST900186727.29
748CAG-177 sp003514385 abundance in stoolGCST900322597.29
749SERPINA3 levelsGCST904705837.28
750Dihexosylceramide (d18:1/22:0) levelsGCST900253487.28
751Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004777.26
752aparc-DKTatlas lh area lingualGCST900032457.25
753Heart valve replaced (PheCode 395.6)GCST904759157.25
754Other chronic ischemic heart disease, unspecified (PheCode 411.8)GCST904759387.25
755CREG1/NAAA ratioGCST903142507.24
756aparc-Desikan lh area lingualGCST900030857.23
757Urinary ethanolamine to urinary creatinine ratioGCST904517177.23
758MYOC/NOTCH3 ratioGCST903155077.21
759systolic blood pressure (SBP, maximum, inv-normal transformed)GCST904764007.21
760AnginaGCST904681097.21
761High density lipoprotein cholesterol levelsGCST902786357.21
762Volume of right whole amygdalaGCST904749317.21
763Optic cup areaGCST0041377.21
764aparc-pial rh area parstriangularisGCST900031937.20
765IDP dMRI TBSS MD Retrolenticular part of internal capsule RGCST900040477.19
766Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021667.18
767T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52)GCST903208717.15
768Childhood maltreatmentGCST905518447.15
769BA-exvivo lh thickness BA4pGCST900035187.15
770IDP dMRI ProbtrackX L2 ifo lGCST900042857.15
771Metabolic syndromeGCST904444897.14
772Polycythemia, secondary (PheCode 289.8)GCST904758227.14
773FNDC1 levelsGCST904692567.14
774Heart attackGCST904681327.13
775Heart attackGCST904752117.13
776Unstable angina pectorisGCST900187127.12
777DTI TBSS FA Posterior corona radiata RGCST903844067.12
778high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753527.11
779aseg global volume 4th-VentricleGCST900026007.10
780LGALS3 levelsGCST901793037.09
781CRH levelsGCST904688627.08
782NCS1/NPY ratioGCST903155277.06
783IDP dMRI TBSS L3 FornixGCST900041767.06
784Fasciitis | musculoskeletalUKBB000002397.05
785Occlusion and stenosis of precerebral arteries (PheCode 433.1)GCST904759867.05
786GGCT levelsGCST904693347.05
787CD300LG levelsGCST904686237.04
788aparc-pial rh area lateraloccipitalGCST900031847.03
789Skin yellow/blue componentGCST903202597.01
790Intrahepatic cholestasis of pregnancyGCST904541997.01
791Total body bone mineral density (age 45-60)GCST0053506.99
792Pulse wave reflection index | Arterial stiffnessUKBB000007266.99
793Epstein-Barr virus EA-D antibody levelsGCST900068986.98
794PolyarthrosisFING000011816.98
795AGRN/BTN2A1 ratioGCST903131996.97
796TP53I3 levelsGCST904709376.96
797CD200 levelsGCST904686066.95
798IDP dMRI TBSS L3 Retrolenticular part of internal capsule RGCST900041916.95
799wg rh intensity-contrast parstriangularisGCST900038466.94
800TNFRSF4/TNFRSF9 ratioGCST903159396.94
801Coronary atherosclerosis (PheCode 411.4)GCST904759366.93
802LEPR/NTRK2 ratioGCST903153136.93
803rfMRI connectivity ICA-features 4GCST900063426.93
804aparc-Desikan lh volume parsopercularisGCST900027856.91
805Autorefraction - 6mm asymmetry angle (left) | EyesightUKBB000000726.91
806Ascending aorta diameterGCST900910506.90
807T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903209286.89
808IDP dMRI ProbtrackX L2 ifo rGCST900042866.89
809BA-exvivo lh thickness BA1GCST900035136.88
810IDP T1 FAST ROIs L pallidumGCST900025536.87
811Total protein levelsGCST900187566.87
812Operative procedures - Carpal tunnel release | Summary OperationsUKBB000005746.86
813Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB000006006.86
814EFNA1 levelsGCST904690806.84
815CPM levelsGCST902405986.83
816IDP dMRI TBSS MD Superior fronto-occipital fasciculus LGCST900040706.82
817ROBO1/SPON1 ratioGCST903157836.81
818CLUL1 levelsGCST904687926.79
819INHBB levelsGCST904696146.78
820rfMRI amplitudes (ICA100 node 40)GCST900046286.78
821Ischemic heart disease (PheCode 411)GCST904759296.77
822S100A12 levelsGCST904705136.77
823wg rh intensity-contrast parahippocampalGCST900038426.77
824Enteritis due to Yersinia enterocoliticaFING000005056.77
825aparc-a2009s rh area Pole-occipitalGCST900034126.75
826ITGA2 levelsGCST904696346.75
827Systolic blood pressure (standard GWA)GCST902673046.74
828Triglyceride to HDL cholesterol ratioGCST902959496.74
829Nonalcoholic fatty liver diseaseGCST902750416.73
830MPO levelsGCST904699376.73
831Spinal stenosis of lumbar region (PheCode 720.1)GCST904762346.72
832Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457)GCST902695546.72
833CCL14 levelsGCST904685666.71
834Fibromuscular dysplasiaGCST900266126.70
835CAG-177 abundance in stoolGCST900322616.69
836aparc-DKTatlas lh area cuneusGCST900032376.69
837Torso length to body height ratioGCST902702626.69
838Haematocrit percentage (UKB data field 30030)GCST904680736.66
839CCN3/PGF ratioGCST903137226.66
840T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93)GCST903209126.65
841Triacylglycerol_53:5_[M+NH4]1+ levelsGCST900605206.65
842F3 levelsGCST904691706.65
843FSTL3/SPON2 ratioGCST903148846.64
844X-24337 levelsGCST902006296.63
845Cholesteryl Esters in HDLGCST904973686.63
846IDP dMRI TBSS L2 Cingulum hippocampus RGCST900041596.63
847CD70 levelsGCST904686456.60
848Osteomyelitis (PheCode 710.1)GCST904762216.59
849N-acetyl-2-aminoadipate levelsGCST902002686.59
850IDP dMRI TBSS MD FornixGCST900040326.59
851IDP dMRI TBSS L3 Sagittal stratum LGCST900042026.58
852T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST903206916.57
853Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453)GCST902695506.57
854Phospholipids in large HDL (UKB data field 23560)GCST902696576.57
855Coronary artery bypass graftingFING000003586.57
856RBP2 levelsGCST904704386.57
857IDP dMRI ProbtrackX MD atr lGCST900042216.57
858IDP dMRI ProbtrackX OD str rGCST900044746.56
859Phospholipids in large VLDLGCST904982436.56
860Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST902695326.56
861ACVRL1/TNFRSF19 ratioGCST903131596.54
862CDHR2 levelsGCST904686796.54
863rfMRI amplitudes (ICA100 node 27)GCST900046156.54
864NEO1 levelsGCST904700296.53
865CLMP/TGFBR2 ratioGCST903141356.53
866Total testosterone levelsGCST902398206.52
867NAAA levelsGCST904699916.52
868CD40LG/TNFSF14 ratioGCST903138276.51
869LTBR levelsGCST902431766.51
870Acetabular diameterGCST904489066.49
871aparc-DKTatlas rh area lateraloccipitalGCST900032746.49
872EndometriosisGCST900186196.48
873IDP dMRI ProbtrackX L3 ifo lGCST900043126.47
874Pulse pressureGCST900187506.47
875Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levelsGCST902000176.46
876ISLR2 levelsGCST904696296.45
877IDP dMRI ProbtrackX MD ilf rGCST900042346.45
878Left ventricular wall thickness (maximal)GCST904352636.43
879IDP dMRI TBSS L3 Cerebral peduncle RGCST900041856.42
880Delta body mass index (difference between ECG-predicted and measured)GCST904290626.42
881HAMP levelsGCST904516836.39
882Phospholipids to Total Lipids in Large HDL percentageGCST904978636.39
883high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753566.39
884Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levelsGCST900602806.38
885PARK7/TNFRSF9 ratioGCST903155996.38
886HDL cholesterol levelsGCST904973526.37
887Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6)GCST904760946.37
888Phospholipids to total lipids ratio in large VLDLGCST900928776.37
889Inguinal herniaGCST900186486.36
890Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025806.36
891Diarrhoea and gastroenteritis of presumed infectious originFING000004206.35
892DSG4 levelsGCST904690446.35
893ANGPTL3/TFPI ratioGCST903132706.35
894Takes medication for coronary artery/ coronary heart disease?GCST904751996.34
895PLA2G15/PRCP ratioGCST903156616.34
896T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209206.33
897Systolic blood pressureGCST903016956.33
898AHCY/HSPA1A ratioGCST903132116.33
899Triglycerides in very large VLDL (UKB data field 23494)GCST902695916.32
900ALB levelsGCST904971016.30
901KDR/VWF ratioGCST903152456.29
902aparc-a2009s rh area S-collat-transv-antGCST900034206.28
903Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695786.28
904Prescriptions - anti-malarialUKBB000006636.28
905Prescriptions - quinine bisulfate | anti-malarialUKBB000006986.28
906End-diastolic bi-ventricular shape (principal component 5)GCST904484846.27
907IDP dMRI ProbtrackX L1 ptr lGCST900042656.27
908Cholesteryl Esters to Total Lipids in Large HDL percentageGCST904977636.25
909IL17D levelsGCST904695606.25
910Ascending aorta strainGCST902673886.24
911SLC39A5 levelsGCST904706616.24
912aseg rh intensity Thalamus-ProperGCST900037826.23
913COL6A3 levelsGCST904688216.23
914Total lipids in very large VLDL (UKB data field 23489)GCST902695866.22
915NXPH3 levelsGCST904701126.21
916Chronic rhinitis, nasopharyngitis and pharyngitisFING000002976.21
917PPP2R2A levelsGCST906181226.19
918Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485)GCST902695826.19
919aparc-Desikan lh area cuneusGCST900030776.19
920Hypermetropia (PheCode 367.8)GCST904758826.17
921aparc-Desikan rh area lateraloccipitalGCST900031176.17
9224-hydroxyglutamate levelsGCST901998906.17
923aparc-DKTatlas rh thickness cuneusGCST900035746.16
924Total lipids in large HDLGCST904978156.15
925Chronic Kidney Disease, Stage IV (PheCode 585.34)GCST904761306.14
926Spinal stenosis (PheCode 720)GCST904762336.13
927Coronary atherosclerosis | circulatory systemUKBB000001526.13
928C3 levelsGCST904684986.13
929ITGAV levelsGCST904696396.13
930MEGF9 levelsGCST904698846.12
931Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST902695816.12
932Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivityGCST903027196.12
933CDH5/ENG ratioGCST903139546.11
934OsteoarthritisGCST904681446.10
935Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST902695806.09
936Noninflammatory disorders of female genital tractFING000008826.09
937IDP dMRI TBSS FA Tapetum LGCST900039246.09
938Diverticular disease of intestineFING000004716.08
939Hammer toe (acquired) (PheCode 735.21)GCST904762506.08
940GDNF levelsGCST904693236.08
941Volume of right cortico-amygdaloid transition areaGCST904749136.07
942Macular cystFING000007436.07
943BMPER levelsGCST904684556.06
944DTI TBSS L2 Uncinate fasciculus LGCST903845216.06
945F7/VASN ratioGCST903147456.06
946Pulse wave peak to peak time | Arterial stiffnessUKBB000007256.05
947CD48 levelsGCST904256766.05
948IDP T1 FAST ROIs L cuneal cortexGCST900025136.05
949Dry age-related macular degeneration (includes geographic atrophy)FING000004806.05
950aparc-a2009s rh area S-centralGCST900034156.05
951T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903208976.04
952Bone marrow fat fraction of left proximal femurGCST906523926.03
953Other headache syndromesFING000010556.02
954aparc-a2009s rh thickness G-cuneusGCST900036876.01
955DTI autoptx L3 str l tractGCST903852166.01
956rfMRI connectivity (ICA100 edge 380)GCST900052336.01
957TXN levelsGCST904709956.00
958Metabolic disorder, other/unspecifiedFING000008156.00
959DAB2/TBL1X ratioGCST903143686.00
960PTPRM levelsGCST904703845.99
961CNTN5 levelsGCST904688075.99
962X-25371 levelsGCST902006565.98
963Valvular heart disease excluding rheumatic feverFING000014145.98
964Serine levelsGCST902004155.97
965Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T37ECGU0000375.97
966C-reactive protein levels (CRP.4337.49.2)GCST902405035.97
967IDP dMRI ProbtrackX MD cgc lGCST900042235.96
968TGFBR3 levelsGCST904708485.96
969NHLRC3 levelsGCST904700465.96
970Illnesses of siblings - Heart disease | Family historyUKBB000003515.95
971Cholesterol to Total Lipids in Large HDL percentageGCST904977305.95
972RBP7 levelsGCST904704405.95
973Average diameter for HDL particlesGCST904974545.93
974Non-cancer illness code, self-reported - angina | Medical conditionsUKBB000005055.93
975aparc-Desikan rh volume parstriangularisGCST900028205.92
976CFB levelsGCST902407785.92
977EndometriosisFING000004975.91
978Cholesterol in Medium HDLGCST904984955.90
979MOG/RTBDN ratioGCST903154765.90
980FAM3B/FGF19 ratioGCST903147765.90
981FOXJ3 levelsGCST904692645.89
982T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903209445.89
983Physical function (baseline)GCST905658375.89
984Nonalcoholic fatty liver diseaseGCST900547825.88
985Chronic obstructive pulmonary diseaseGCST900185875.87
986CR2 levelsGCST904688525.86
987CPXM2 levelsGCST904688505.86
988T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903206445.85
989Lymphoid leukemia, chronic (PheCode 204.12)GCST904756135.85
990IDP dMRI ProbtrackX MD cst lGCST900042275.83
991IDP dMRI TBSS L2 FornixGCST900041285.83
992IDP dMRI TBSS L2 Pontine crossing tractGCST900041245.82
993CTSZ/NAAA ratioGCST903143205.82
994Volume of left lateral nucleusGCST904749705.82
995HDL cholesterol | Blood biochemistryUKBB000003065.82
996GGT5 levelsGCST904693375.82
997IDP dMRI ProbtrackX FA ifo rGCST900039385.81
998Triglyceride to phosphoglyceride ratioGCST904999965.81
999Hair/balding pattern: Pattern 4 (UKB data field 2395_4)GCST900436195.80
1000Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762685.79